1. Zhang, Xiaoqing, Dou, Peng, Akhtar, Muhammad Luqman, Nie, Huan, Li, Yu. 2021. NEU4 inhibits motility of HCC cells by cleaving sialic acids on CD44. In Oncogene, 40, 5427-5440. doi:10.1038/s41388-021-01955-7. https://pubmed.ncbi.nlm.nih.gov/34282273/
2. Silvestri, I, Testa, F, Zappasodi, R, Venerando, B, Tringali, C. 2014. Sialidase NEU4 is involved in glioblastoma stem cell survival. In Cell death & disease, 5, e1381. doi:10.1038/cddis.2014.349. https://pubmed.ncbi.nlm.nih.gov/25144716/
3. Shi, Jie, Zhou, Rui, Wang, Shuo, Li, Jia, Wang, Longlong. 2024. NEU4-mediated desialylation enhances the activation of the oncogenic receptors for the dissemination of ovarian carcinoma. In Oncogene, 43, 3556-3569. doi:10.1038/s41388-024-03187-x. https://pubmed.ncbi.nlm.nih.gov/39402373/
4. Seyrantepe, Volkan, Canuel, Maryssa, Carpentier, Stéphane, Levade, Thierry, Pshezhetsky, Alexey V. 2008. Mice deficient in Neu4 sialidase exhibit abnormal ganglioside catabolism and lysosomal storage. In Human molecular genetics, 17, 1556-68. doi:10.1093/hmg/ddn043. https://pubmed.ncbi.nlm.nih.gov/18270209/
5. Cai, Bi-He, Wu, Po-Han, Chou, Chi-Kan, Chen, Jang-Yi, Kannagi, Reiji. 2019. Synergistic activation of the NEU4 promoter by p73 and AP2 in colon cancer cells. In Scientific reports, 9, 950. doi:10.1038/s41598-018-37521-7. https://pubmed.ncbi.nlm.nih.gov/30700826/
6. Glanz, Victor Yu, Myasoedova, Veronika A, Grechko, Andrey V, Orekhov, Alexander N. 2018. Sialidase activity in human pathologies. In European journal of pharmacology, 842, 345-350. doi:10.1016/j.ejphar.2018.11.014. https://pubmed.ncbi.nlm.nih.gov/30439363/
智鼠故事 
